Dynavax Technologies
DVAX
#5493
Rank
A$1.94 B
Marketcap
A$16.53
Share price
-0.09%
Change (1 day)
-17.49%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.42 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is A$0.42 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$0.40 B8.47%
2023-12-31A$0.37 B-0.54%
2022-12-31A$0.37 B6.8%
2021-12-31A$0.35 B25.31%
2020-12-31A$0.28 B-8.36%
2019-12-31A$0.30 B115.91%
2018-12-31A$0.14 B
2014-12-31A$11.68 M
2012-12-31N/A-100%
2011-12-31A$12.49 M7.71%
2010-12-31A$11.59 M-15.85%
2009-12-31A$13.78 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
A$69.04 M-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$9.94 B 2,212.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$62.41 B 14,415.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$37.62 B 8,650.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$49.22 B 11,348.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
A$35.99 B 8,271.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$91.78 B 21,248.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$25.75 B 5,890.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
A$82.34 B 19,051.72%๐Ÿ‡บ๐Ÿ‡ธ USA